Ironwood Pharmaceuticals Inc (IRWD)

14.69
NASDAQ : Health Care
Prev Close 14.69
Day Low/High 0.00 / 0.00
52 Wk Low/High 7.35 / 16.89
Avg Volume 1.41M
Exchange NASDAQ
Shares Outstanding 146.22M
Market Cap 2.25B
EPS -1.00
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Ironwood Pharmaceuticals Provides Third Quarter 2016 Investor Update

Ironwood Pharmaceuticals Provides Third Quarter 2016 Investor Update

Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD), a commercial biotechnology company, today provided an update on its third quarter 2016 results and recent business activities.

Ironwood Pharmaceuticals To Present At Credit Suisse 25th Annual Healthcare Conference

Ironwood Pharmaceuticals To Present At Credit Suisse 25th Annual Healthcare Conference

Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) will present a corporate update at the Credit Suisse 25 th Annual Healthcare Conference on Tuesday, November 8th, 2016 at 2:00 p.

Ironwood Highlights Breadth Of Gout Research With Presentations At The American College Of Rheumatology 2016 Annual Meeting

Ironwood Highlights Breadth Of Gout Research With Presentations At The American College Of Rheumatology 2016 Annual Meeting

Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) today announced a series of oral and poster presentations to be presented at the upcoming American College of Rheumatology (ACR) Annual Meeting in Washington, D.

Ironwood Pharmaceuticals To Host Third Quarter 2016 Investor Update Call

Ironwood Pharmaceuticals To Host Third Quarter 2016 Investor Update Call

Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) today announced it will host its third quarter 2016 investor update conference call and webcast at 8:30 a.

Nine In Ten Physicians Agree Target Goal For Gout Is Imperative, Yet Half Of Patients Fail To Reach It, New Survey Shows

Nine In Ten Physicians Agree Target Goal For Gout Is Imperative, Yet Half Of Patients Fail To Reach It, New Survey Shows

A new survey conducted among primary care physicians and rheumatologists found that despite their overall agreement that gout is a serious and chronic medical condition with potential long-term consequences, patients remain...

ZURAMPIC® (lesinurad) Is Now Available In Pharmacies Throughout The United States. (Photo: Business Wire)

ZURAMPIC® (lesinurad) Is Now Available In Pharmacies Throughout The United States. (Photo: Business Wire)

Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) today announced that ZURAMPIC ® (lesinurad) is now available in pharmacies throughout the United States.

Ironwood Closes $150 Million Debt Refinancing

Ironwood Closes $150 Million Debt Refinancing

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) today announced the closing of a $150 million debt refinancing.

Ironwood Pharmaceuticals To Present At Morgan Stanley Global Healthcare Conference

Ironwood Pharmaceuticals To Present At Morgan Stanley Global Healthcare Conference

Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) will participate in a fireside chat at the Morgan Stanley Global Healthcare Conference on Monday, September 12, 2016 at 9:55 a.

Ironwood Pharmaceuticals To Present At Wells Fargo 2016 Healthcare Conference

Ironwood Pharmaceuticals To Present At Wells Fargo 2016 Healthcare Conference

Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) will present a corporate update at the Wells Fargo 2016 Healthcare Conference on Wednesday, September 7, 2016 at 2:20 p.

Ironwood Pharmaceuticals (IRWD): Today's Weak On High Volume Stock

Ironwood Pharmaceuticals (IRWD): Today's Weak On High Volume Stock

Trade-Ideas LLC identified Ironwood Pharmaceuticals (IRWD) as a weak on high relative volume candidate

Ironwood Pharmaceuticals Provides Second Quarter 2016 Investor Update

Ironwood Pharmaceuticals Provides Second Quarter 2016 Investor Update

Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD), a commercial biotechnology company, today provided an update on its second quarter 2016 results and recent business activities.

Synergy Pharma Offers Lots of Synergies

Synergy Pharma Offers Lots of Synergies

I expect Allergan or another player to bid for SGYP soon.

Ironwood Pharmaceuticals To Host Second Quarter 2016 Investor Update Call

Ironwood Pharmaceuticals To Host Second Quarter 2016 Investor Update Call

Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) today announced it will host its second quarter 2016 investor update conference call and webcast at 4:30 p.

3 Stocks Pushing The Health Services Industry Higher

3 Stocks Pushing The Health Services Industry Higher

TheStreet highlights 3 stocks pushing the drugs industry higher today.

Strong On High Relative Volume: Ironwood Pharmaceuticals (IRWD)

Strong On High Relative Volume: Ironwood Pharmaceuticals (IRWD)

Trade-Ideas LLC identified Ironwood Pharmaceuticals (IRWD) as a strong on high relative volume candidate

Insider Trading Alert - WTS, IRWD And SALM Traded By Insiders

Insider Trading Alert - WTS, IRWD And SALM Traded By Insiders

Stocks with insider trader activity include WTS, IRWD and SALM

Ironwood Pharmaceuticals To Present At Jefferies 2016 Healthcare Conference

Ironwood Pharmaceuticals To Present At Jefferies 2016 Healthcare Conference

Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) will present a corporate update at the Jefferies 2016 Healthcare Conference on Friday, June 10, 2016 at 2:30 p.

Ironwood Pharmaceuticals Closes U.S. Transaction With AstraZeneca For Lesinurad

Ironwood Pharmaceuticals Closes U.S. Transaction With AstraZeneca For Lesinurad

Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) announced today that it has closed the previously-announced transaction with AstraZeneca for the exclusive U.

Ironwood Pharmaceuticals To Present At Goldman Sachs 37th Annual Global Healthcare Conference

Ironwood Pharmaceuticals To Present At Goldman Sachs 37th Annual Global Healthcare Conference

Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) will present a corporate update at the Goldman Sachs 37 th Annual Global Healthcare Conference on Tuesday, June 7, 2016 at 4:00 p.

IRWD July 15th Options Begin Trading

IRWD July 15th Options Begin Trading

Investors in Ironwood Pharmaceuticals Inc. saw new options begin trading today, for the July 15th expiration.

Ironwood Pharmaceuticals To Present At 2016 UBS Global Healthcare Conference

Ironwood Pharmaceuticals To Present At 2016 UBS Global Healthcare Conference

Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) will present a corporate update at the 2016 UBS Global Healthcare Conference on Wednesday, May 25, 2016 at 9:00 a.

Ironwood Pharmaceuticals To Present Linaclotide Data At Digestive Disease Week® 2016

Ironwood Pharmaceuticals To Present Linaclotide Data At Digestive Disease Week® 2016

Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) today announced the presentation of linaclotide-related clinical and preclinical data from the company and its collaborators during Digestive Disease Week® (DDW)...

Ironwood Pharmaceuticals Provides First Quarter 2016 Investor Update

Ironwood Pharmaceuticals Provides First Quarter 2016 Investor Update

Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD), a commercial biotechnology company, today provided an update on its first quarter 2016 results and recent business activities.

Ironwood Pharmaceuticals To Present At Bank Of America Merrill Lynch 2016 Health Care Conference

Ironwood Pharmaceuticals To Present At Bank Of America Merrill Lynch 2016 Health Care Conference

Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) will present a corporate update at the Bank of America Merrill Lynch 2016 Health Care Conference on Tuesday, May 10, 2016 at 3:40 p.

Today's Dead Cat Bounce Stock: Ironwood Pharmaceuticals (IRWD)

Today's Dead Cat Bounce Stock: Ironwood Pharmaceuticals (IRWD)

Trade-Ideas LLC identified Ironwood Pharmaceuticals (IRWD) as a "dead cat bounce" (down big yesterday but up big today) candidate